Successful treatment with subcutaneous ofatumumab in an adolescent patient with refractory myelin oligodendrocyte glycoprotein-immunoglobulin G-associated disease (MOGAD)

Preventing relapse of myelin oligodendrocyte glycoprotein-immunoglobulin G-associated disease (MOGAD) with steroids and immunosuppressants is sometimes difficult. There is no standard treatment for refractory cases. We present the case of a 17-year-old female patient with longitudinally extensive my...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Satomi Hiya, Hajime Yoshimura, Michi Kawamoto
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Elsevier 2023-06-01
Schriftenreihe:	eNeurologicalSci
Schlagworte:	Myelin oligodendrocyte glycoprotein-immunoglobulin G-associated disease (MOGAD) Adolescent Neuromyelitis optica spectrum disorder (NMOSD) Multiple sclerosis (MS) Ofatumumab
Online-Zugang:	http://www.sciencedirect.com/science/article/pii/S2405650223000199
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!